Skip to main content
Equibles

INDGN · Indegene Limited

Use INDGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INDGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
665.45 INR -0.40 (-0.06%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 71.64K Avg daily vol (3M) 99.5K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close665.45 INR Open665.85 INR Day659.50–677.00 INR 52W close424.30–665.85 INR Avg vol 30d115K Last earningsOct 30, 2026 DataMay 2024–Nov 2026

Latest documents

2026
Oct 30
Earnings call
EBITDA rises 32%; quarterly margin outlook unchanged

Indigene reported second-quarter EBITDA growth of 32% year-on-year and nine deal wins. Management maintained its outlook of quarterly EBITDA margins of 19% plus by the fourth quarter of this year.

4 source passages
Thank you, Moderator. A very good morning to all of you, and thank you for joining us today for Indigene's Earnings Conference Call for the second quarter and half year ended, financial year 2027. Revenue for the second quarter was rupees 11,000 to 23 million, or U.S. dollar 117.5 million. In dollar terms, that is a strong growth of 27.5% year-on-year and 4.4% sequentially. EBITDA came in at rupees 1,873 million, up 32% year-on-year, at a margin of 16.7%. We had a good quarter in terms of deal wins. Nine deal wins with annual contract values about $1 million, including three large deals, one in the $5 million plus range and two in the $3 to $5 million range. Our outlook remains unchanged. We continue on the path to quarterly EBITDA margins of 19% plus by the fourth quarter of this year. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
· 7.20B INR 1.10B INR '25 Q3 ▲12.3% 7.56B INR 1.18B INR '25 Q4 ▲12.5% 7.61B INR 1.16B INR '26 Q1 ▲17.1% 8.04B INR 0 INR '26 Q2 ▲30.8% 9.42B INR 1.03B INR '26 Q3 ▲32.8% 10.03B INR 797.00M INR '26 Q4 ▲39.7% 10.63B INR 1.16B INR '27 Q1 LATEST ▲39.6% 11.22B INR 1.12B INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 424.30 INR Now 665.45 INR · 100% Range high 665.85 INR
vs 200-day avg +26% vs 50-day avg +11%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:INDGN +9.2% +12.3% +31.5% +13.2% +27.8%

Exchange listing

Market
XBOM
Ticker
INDGN
ISIN
INE065X01017
Security
Ordinary share
Trading currency
INR

Company

Website
https://www.indegene.com/
Investor relations
https://ir.indegene.com/en/investor-relations/

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-07-31 2.25 INR
2025-06-13 2.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-10-30 Audio Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-07-31 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-04-30 Audio Transcript
    Earnings Call for the Quarter Ended March 31, 2026